Clinical Trials Directory

Trials / Terminated

TerminatedNCT05082103

Effect of Enzymes on Dental Biofilm Accumulation in Healthy Individuals

Effect of Enzyme-containing Lozenges on Dental Biofilm Accumulation in Healthy Individuals: A Randomized Placebo-controlled Clinical Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Novozymes A/S · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to assess the effect of enzyme containing lozenges on dental plaque accumulation in healthy adults.

Detailed description

The purpose of the study is to examine the clinical effects of lozenges containing three extracellular matrix-degrading enzymes on dental plaque accumulation and removal, prevention of gingivitis, and oral microbiome composition after professional tooth cleaning, as compared to a placebo lozenge without enzymes. Two different concentrations of the enzymes will be tested, to investigate a potential dose-dependent effect of the enzymes. Furthermore, safety of the enzyme lozenge will be assessed by clinical evaluation of the oral mucosa. The null hypothesis is that treatment with enzyme-containing lozenges does not affect plaque accumulation as compared to a placebo control.

Conditions

Interventions

TypeNameDescription
OTHEREnzyme lozenge 1Participants are instructed to take one enzyme containing lozenge three times daily, at least 30 min after a meal, for 14 days. No normal oral hygiene procedures are allowed during the intervention period.
OTHEREnzyme lozenge 2Participants are instructed to take one lozenge with 3x higher enzyme concentration three times daily, at least 30 min after a meal, for 14 days. No normal oral hygiene procedures are allowed during the intervention period.
OTHERPlacebo lozengeParticipants are instructed to take one placebo lozenge three times daily, at least 30 min after a meal, for 14 days. No normal oral hygiene procedures are allowed during the intervention period.

Timeline

Start date
2021-09-15
Primary completion
2022-03-31
Completion
2022-03-31
First posted
2021-10-18
Last updated
2022-06-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05082103. Inclusion in this directory is not an endorsement.